Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors

乳腺癌和前列腺癌幸存者寻求后续护理的预测因素

基本信息

项目摘要

DESCRIPTION (provided by applicant): Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors By 2050 the estimated number of cancer survivors will surpass new cancer cases, putting great demands on service providers and systems of care. More than half of individuals already diagnosed with cancer are expected to survive for more than 5 years. For breast and prostate cancers survival exceeds 88%. The American Society of Clinical Oncology projects a medical oncologist shortage by 2020 that will necessitate a multifaceted strategy to meet future cancer follow-up care demands. Therefore, primary care providers (PCPs) are increasingly being called upon to provide a "medical home" (i.e., usual source of care) for cancer survivors who have completed treatment. Currently one third of the 36.6 million physician office visits made for cancer care annually are made to PCPs. A study of SEER linked Medicare data reports that greater proportions of long-term breast and prostate cancer survivors (75% of those surviving 5+ yrs) receive care from primary care providers than cancer and cancer related specialists. Several studies suggest that survivors who see both oncologists and primary care physicians are more likely to receive recommended follow-up care than patients who see one or the other. Yet, there is little research that examines how patients think about their options for care, their decision making processes or the impact of these factors on receiving quality follow-up care. There is also limited research on cancer survivors who receive their treatment in community settings. While most adult cancer survivors in the US are treated for their cancers in community settings, much of the current survivorship research comes from patients treated at NCI designated comprehensive cancer centers. We address these important knowledge gaps in the proposed study. Specific aims of the study are to: (1) implement a survey study of adult cancer survivors treated in community settings that assesses and measures their primary care use and attitudes regarding their follow-up cancer care; (2) describe primary care usage of breast and prostate cancer survivors for follow-up care and recurrence surveillance; and, (3) assess cognitive- affective, patient support and demographic factors that affect how survivors use oncology specialists and PCPs for follow-up care. This descriptive, cross-sectional study of breast and prostate cancer survivors (n=400) will be conducted with patients treated at six community hospitals reflective of the diversity of community cancer treatment experiences in the state of NJ. Study results will provide a sound empirical basis for the development of interventions that enhance survivor care plans and optimize follow-up care in cancer survivor populations.
描述(由申请人提供):到2050年,乳腺癌和前列腺癌幸存者之间寻求随访护理的预测因素,估计的癌症幸存者数量将超过新的癌症病例,对服务提供者和护理系统提出了很大的要求。预计已经诊断出患有癌症的人中有一半以上将存活超过5年。对于乳房和前列腺癌的生存率超过88%。美国临床肿瘤学会预计,到2020年,医学肿瘤学家短缺将需要采取多方面的策略来满足未来的癌症随访需求。因此,越来越多地要求初级保健提供者(PCP)为已完成治疗的癌症幸存者提供“医疗家庭”(即通常的护理来源)。目前,每年为PCP进行癌症护理的3660万医师办公室就诊中的三分之一。一项有关SEER联系的Medicare数据报告的研究是,长期乳腺癌和前列腺癌幸存者(75%幸存5年以上的人)从初级保健提供者那里获得了医疗服务,而不是癌症和癌症与癌症相关的专家。几项研究表明,与看到一名或另一个人的患者相比,看到肿瘤学家和初级保健医生的幸存者更有可能接受推荐的后续护理。然而,几乎没有研究研究患者如何看待他们的护理选择,决策过程或这些因素对接受质量随访护理的影响。关于在社区环境中接受治疗的癌症幸存者的研究也有限。尽管在社区环境中,大多数美国成年癌症幸存者都接受了癌症的治疗,但目前的许多生存研究都来自NCI指定综合癌症中心接受治疗的患者。我们在拟议的研究中解决了这些重要的知识差距。该研究的具体目的是:(1)对在社区环境中接受治疗的成年癌症幸存者进行调查研究,以评估和衡量其初级保健使用和对其随访癌症护理的态度; (2)描述乳腺癌和前列腺癌幸存者的初级保健用于后续护理和复发监测; (3)评估影响幸存者如何使用肿瘤专家和PCP进行后续护理的认知情感,患者支持和人口统计学因素。这项对乳腺癌和前列腺癌幸存者的描述性,横断面研究(n = 400)将在六家社区医院接受治疗的患者进行,反映了NJ状况的社区癌症治疗经历的多样性。研究结果将为开发干预措施提供合理的经验基础,以增强幸存者护理计划并优化癌症幸存者人群的后续护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHAWNA V. HUDSON其他文献

SHAWNA V. HUDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHAWNA V. HUDSON', 18)}}的其他基金

Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance
使用量身定制的移动医疗干预措施来减少城市宫颈癌的差异,以提高阴道镜检查的出勤率
  • 批准号:
    10659894
  • 财政年份:
    2023
  • 资助金额:
    $ 8.85万
  • 项目类别:
Re-entry Supplement to Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者 (EXCELS) 扩展癌症教育的重返补充
  • 批准号:
    8843650
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8743195
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9379052
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9326812
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8917755
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8641008
  • 财政年份:
    2013
  • 资助金额:
    $ 8.85万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8700941
  • 财政年份:
    2011
  • 资助金额:
    $ 8.85万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8230599
  • 财政年份:
    2011
  • 资助金额:
    $ 8.85万
  • 项目类别:
Life After Cancer: Examining Survivor Transitions From Specialist to Primary Care
癌症后的生活:检查幸存者从专科护理到初级护理的转变
  • 批准号:
    8700972
  • 财政年份:
    2008
  • 资助金额:
    $ 8.85万
  • 项目类别:

相似国自然基金

儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
  • 批准号:
    32371121
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
  • 批准号:
    32200888
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
  • 批准号:
    82173590
  • 批准年份:
    2021
  • 资助金额:
    56.00 万元
  • 项目类别:
    面上项目

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 8.85万
  • 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
  • 批准号:
    10822202
  • 财政年份:
    2024
  • 资助金额:
    $ 8.85万
  • 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
  • 批准号:
    10752276
  • 财政年份:
    2024
  • 资助金额:
    $ 8.85万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 8.85万
  • 项目类别:
Iron deficits and their relationship with symptoms and cognition in Psychotic Spectrum Disorders
铁缺乏及其与精神病谱系障碍症状和认知的关系
  • 批准号:
    10595270
  • 财政年份:
    2023
  • 资助金额:
    $ 8.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了